FUNDING CALLS
Current funding opportunities
Open funding calls with no closing date can be found on a separate page below
UK Japan Engineering Biology for Novel Therapies and Diagnostics Research Collaboration
Medical Research Council (MRC)
16 April 2024
Not stated
3 years
This funding opportunity aims to support ‘cutting edge’ fundamental or translational research projects by delivering joint funding for innovative collaborations between researchers from Japan and the UK in the field of engineering biology for novel therapies and diagnostics.
Japan-UK Engineering Biology for Discovery Research and Cross-Cutting Technologies
Biotechnology and Biological Sciences Research Council (BBSRC)
16 April 2024
£1 million
3 years
Based on the implementation principles of the ASPIRE program in Japan and the ISPF in the UK, this partnership program aims to support internationally competitive collaborative research projects between Japan and the UK focusing on the fundamentals of engineering biology and cross-cutting technologies, creating leading international researcher networks, and nurturing early career researchers to drive tomorrow’s engineering biology.
Experimental Medicine Stage One
Medical Research Council (MRC)
17 April 2024
No limit
No limit
Apply for funding to investigate the causes, progression and treatment of human disease. Successful projects will produce new mechanistic insights including those that may identify opportunities to modify disease pathways or enable the future development of novel therapeutic or diagnostic approaches.
23/170 EME Platform studies to efficiently evaluate the efficacy of multiple interventions
National Institute for Health and Care Research (NIHR)
23 April 2024
Not stated
Not stated
The Efficacy and Mechanism Evaluation (EME) Programme is accepting Stage 1 applications to their commissioned workstream. The EME Programme supports translational research evaluating a wide range of novel or repurposed interventions and technologies. These may include but are not limited to diagnostic or prognostic tests and decision-making tools, drugs or biological compounds, behavioural therapies, medical devices, and public health initiatives delivered within the NHS.
23/144 Healthy homes
National Institute for Health and Care Research (NIHR)
23 April 2024
Not stated
Not stated
The Public Health Research (PHR) Programme funds research to generate evidence to inform the delivery of non-NHS interventions, intended to improve the health of the public, and reduce inequalities in health. The PHR Programme is accepting applications to the commissioned workstream to explore the health and health inequality impacts of interventions affecting the physical quality of UK housing.
23/171 Efficacy and Mechanism Evaluation Programme Researcher-led
National Institute for Health and Care Research (NIHR)
23 April 2024
Not stated
Not stated
The Efficacy and Mechanism Evaluation (EME) Programme supports translational research evaluating a wide range of novel or repurposed interventions and technologies. These may include but are not limited to diagnostic or prognostic tests and decision-making tools, drugs or biological compounds, behavioural therapies, medical devices, and public health initiatives delivered within the NHS.
23/173 NIHR NICE Rolling Call (EME Programme)
National Institute for Health and Care Research (NIHR)
23 April 2024
Not stated
Not stated
The Efficacy and Mechanism Evaluation (EME) Programme supports translational research evaluating a wide range of novel or repurposed interventions and technologies. These may include but are not limited to diagnostic or prognostic tests and decision-making tools, drugs or biological compounds, behavioural therapies, medical devices, and public health initiatives delivered within the NHS.
The programme is interested in receiving applications to meet recommendations in research identified in NICE guidance that has been published or updated since 2015.
23/172 NIHR James Lind Alliance Priority Setting Partnerships Rolling Call (EME Programme)
National Institute for Health and Care Research (NIHR)
23 April 2024
Not stated
Not stated
The Efficacy and Mechanism Evaluation (EME) Programme supports translational research evaluating a wide range of novel or repurposed interventions and technologies. These may include but are not limited to diagnostic or prognostic tests and decision-making tools, drugs or biological compounds, behavioural therapies, medical devices, and public health initiatives delivered within the NHS.
The programme recognises the importance of the research priorities identified by the James Lind Alliance (JLA) Priority Setting Partnerships (PSP) and are interested in receiving high-quality applications for research studies which aim to address them, rather than to conduct a PSP itself.
Smart Grants: Jan 2024
Innovate UK
24 April 2024
See below
See below
The Innovate UK Smart grant has focused scope and eligibility criteria to support SMEs and their partners develop disruptive innovations with significant potential for rapid economic return to the UK. The application process reflects the importance of obtaining economic benefits from public funding, and the potential for successful commercialisation, growth, and exports.
- Projects with a duration of 6 to 18 months must have total eligible project costs between £100,000 and £500,000.
- Projects with a duration of 19 to 24 months must have total eligible project costs between £100,000 and £1 million.
AHRC Responsive Mode: Curiosity Award Round Three
Arts and Humanities Research Council (AHRC)
30 April 2024
£100,000
5 years
Curiosity awards support early-stage ambitious and novel fundamental research which has the potential to act as a springboard towards new and exciting research agendas. The funding opportunity celebrates the full diversity of the arts and humanities. It is flexible, and applications are welcomed from teams, networks, and solo researchers.
AHRC Responsive Mode: Catalyst Award Round Three
Arts and Humanities Research Council (AHRC)
30 April 2024
£300,000
5 years
Catalyst awards support researchers without prior experience of leading a significant research project to accelerate their trajectory as independent researchers, unlocking their potential and building leadership and convenor experience through the delivery of ambitious or complex projects.
24/2 Health Technology Assessment Programme Researcher-led (24/1 primary research, 24/2 evidence synthesis)
National Institute for Health and Care Research (NIHR)
1 May 2024
Not stated
Not stated
The aim of the Health Technology Assessment (HTA) Programme is to ensure that high quality research information on the clinical effectiveness, cost-effectiveness and broader impact of healthcare treatments and tests are produced in the most efficient way for those who plan, provide or receive care from NHS and social care services. In this researcher-led workstream, separate grants are available for primary research and evidence synthesis on topics proposed by the researchers.
24/3 NIHR NICE Rolling Call (HTA Programme)
National Institute for Health and Care Research (NIHR)
1 May 2024
Not stated
Not stated
The aim of the Health Technology Assessment (HTA) Programme is to ensure that high quality research information on the clinical effectiveness, cost-effectiveness and broader impact of healthcare treatments and tests are produced in the most efficient way for those who plan, provide or receive care from NHS and social care services.
The programme is interested in receiving Stage 1 applications to meet recommendations in research identified in NICE guidance that has been published or updated since 2015.
24/4 NIHR James Lind Alliance Priority Setting Partnerships Rolling Call (HTA Programme)
National Institute for Health and Care Research (NIHR)
1 May 2024
Not stated
Not stated
The aim of the Health Technology Assessment (HTA) Programme is to ensure that high quality research information on the clinical effectiveness, cost-effectiveness and broader impact of healthcare treatments and tests are produced in the most efficient way for those who plan, provide or receive care from NHS and social care services.
The NIHR are looking to receive applications for research studies addressing JLA PSPs’ research priorities, rather than to conduct a PSP itself.
UK – Switzerland Collaborative Research and Development: Round 2
Innovate UK
1 May 2024
£450,000
3 years
The aim of this competition is to enhance UK and Swiss collaborations and capabilities in the emerging fields of technology. The result being, the developing and delivering of new innovations and applications of the technologies across a broad range of other sectors.
23/152 Clinical prediction models for early-onset neonatal infection
National Institute for Health and Care Research (NIHR)
22 May 2024
Not stated
Not stated
The Health Technology Assessment (HTA) Programme is accepting applications to their commissioned workstream. The aim of HTA Programme is to ensure that high quality research information on the clinical effectiveness, cost-effectiveness and broader impact of healthcare treatments and tests are produced in the most efficient way for those who plan, provide or receive care from NHS and social care services.
UK – Germany Bilateral: Collaboration R&D Round 3
Innovate UK
3 June 2024
£500,000
3 years
The aim of this competition is to enhance UK and German collaborations and capabilities in the emerging fields of technology in our society. This is to develop and deliver new innovations and applications of the technologies across a broad range of sectors.
Develop Guidance for Better Research Methods
Medical Research Council (MRC) – National Institute for Health and Care Research (NIHR)
12 June 2024
£60,000
18 months
Apply for funding to develop new guidance on biomedical and health research methods. This funding opportunity will support the development of guidance in priority areas of methodological uncertainty, with the aim of catalysing uptake of improved research methods.
PRP (38-01-04) Medical devices in pregnancy and neonatal period
National Institute for Health and Care Research (NIHR)
18 June 2024
£500,000
2 years
The National Institute for Health and Care Research (NIHR) Policy Research Programme (PRP) invites applications for a single research project to explore Equity in Medical Devices during the Pregnancy and Neonatal Period. This research is needed to assess whether there are disparities in the medical devices used during the pregnancy and neonatal period which are contributing to the disparities in maternal and neonatal outcomes. The research is also needed to understand how medical devices could be adapted to ensure equity in maternity and neonatal care.
EPSRC Programme Grant Outline Stage January 2024
Engineering and Physical Sciences Research Council (EPSRC)
25 June 2024
Not stated
2 years
Programme grants provide flexible funding to world-leading research groups seeking to address significant research challenges across the EPSRC remit. We expect most successful applications to be interdisciplinary and collaborative, but they can also address key challenges in a single discipline. They are not just large grants, they must be strategic in nature.
Reducing Compound Pressures on the NHS and Social Care
National Institute for Health and Care Research (NIHR)
26 June 2024
See below
See below
The NIHR wants to generate high-quality research evidence into the evaluation of health and care interventions and services, to reduce compound pressures on the NHS and social care. This cross-programme call for research supports the recently published Department of Health and Social Care Areas of Research Interest, which calls for high quality evidence to support those who plan, commission, manage, deliver and use services across the health, public health and social care sector.
The NIHR programmes participating in this call for research that are still open for applications and their respective closing dates dates are:
- NIHR Academy (opening April 2024)
- Research for Patient Benefit (RfPB), 6 March 2024
- Research Programme for Social Care (RPSC), 26 June 2024
